MedX Health ( (TSE:MDX) ) has provided an update.
MedX Health Corp. has successfully completed the initial closing of its non-brokered private placement, raising $945,000 through the issuance of 13,500,000 units to accredited investors. The funds will be used to further develop the company’s SIAscopy® on DermSecure® telemedicine platform and expand its technology into the occupational health market. This strategic financial move is expected to enhance MedX’s operational capabilities and strengthen its position in the medical device industry.
More about MedX Health
MedX Health Corp., headquartered in Ontario, Canada, is a leading medical device and software company specializing in skin health. The company is known for its SIAscopy® on DermSecure® telemedicine platform, which uses advanced technology to provide non-invasive skin assessments. MedX’s products, including SIAMETRICS®, SIMSYS®, and MoleMate®, are designed to assist in the evaluation of moles and lesions, and are approved for use in multiple countries including Canada, the U.S., and the European Union.
YTD Price Performance: -14.29%
Average Trading Volume: 122,381
Technical Sentiment Signal: Strong Buy
Current Market Cap: C$16.34M
Learn more about MDX stock on TipRanks’ Stock Analysis page.